Professional Documents
Culture Documents
Background
The incidence of In-born Errors (IEMs) in India is reported to be
around 1 in 2,500 to 1 in 5,000 live births.
Newborn Screening enables the early detection of certain genetic,
metabolic, and congenital disorders before symptoms manifest.
Early identification allows for timely intervention and treatment,
often preventing or minimizing the impact of these conditions on
a child’s health. Several factors contribute to the variability in
reported incidence rates, including differences in screening protocols,
awareness, access to healthcare, and regional genetic variations
Objective
To provide healthcare professionals with knowledge, skills, and
insights essential for effective implementation, interpretation, and
management of Newborn screening for the most common
Inborn Errors of Metabolism.
To deepen understanding of the principles, methodologies, and
technologies involved in Laboratory testing for Newborn screening.
To provide insights into the clinical significance of various markers
and abnormalities detected during screening.
To develop collaboration among healthcare professionals
involved in newborn screening, including laboratories, pediatricians,
genetic counselors, and other specialists.
Sample collection techniques, criteria for acceptance and
rejection of samples.
Discuss practical aspects, challenges, and solutions for seamless
implementation within healthcare systems.
Emphasize the importance of patient and family education in
the context of newborn screening.
Who should attend
Clinicians Lab technologists Biochemists Researchers
Companies focusing on IEM, Hb disorders
SCAN HERE
Registration Fee